{"filings":[{"id":103579,"accession_number":"0001493152-26-009156","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2026-03-06T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Iveda Solutions receives Nasdaq bid price deficiency notice; has 180 days to comply","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq letter on March 6, 2026, cites failure to maintain $1 minimum bid price for 30 consecutive business days.","Company has until September 2, 2026 to regain compliance by closing at $1+ for 10 consecutive business days.","If not regained, Nasdaq may delist stock; Iveda can appeal any delisting determination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":103578,"accession_number":"0001493152-26-006726","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2026-02-13T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Iveda raises ~$2M in public offering of 5.7M shares and 11.4M warrants at $0.35/unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering of 5,259,999 shares (or pre-funded warrants for 454,287 shares) and series X warrants for 11,428,572 shares at $0.35/unit.","Gross proceeds ~$2M before placement agent fees; net proceeds for general corporate purposes including R&D and debt repayment.","Placement agent H.C. Wainwright received 7% cash fee ($140k) and warrants for 400k shares at $0.4375.","Company agreed to 12-month restriction on further equity issuances (subject to exceptions) and 6-month ban on variable rate transactions.","Directors and executive officers subject to 30-day lock-up on share sales."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119843,"accession_number":"0001493152-25-027071","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2025-12-10T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Iveda Solutions holds 2024 Annual Meeting; re-elects four directors","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Re-elected directors Farnsworth, Franco, Gillen, Ly; each received ~503k-508k votes for, ~52k-57k withheld.","Broker non-votes of 2,150,944 shares on director elections.","Ratified Weinberg & Company as auditor for FY 2025 with 2,498,581 for, 184,218 against, 28,019 abstained.","Meeting quorum of 2,710,818 shares present (46.5% of outstanding voting capital)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119842,"accession_number":"0001493152-25-024995","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2025-11-25T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Iveda Solutions regains Nasdaq compliance on equity requirement","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq previously warned company for failing $2.5M stockholders' equity minimum.","Q3 2025 10-Q reports stockholders' equity of $3,768,242, curing the deficiency.","Nasdaq Staff confirmed compliance and closed the matter on November 25, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":136403,"accession_number":"0001641172-25-026030","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2025-08-29T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Iveda Solutions shareholders approve issuance of 1.25M warrants at $3.44 per share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved Proposal 5 to issue 625,000 Series A and 625,000 Series B warrants with a $3.44 exercise price.","Votes: 1,253,925 for, 121,349 against, 34,141 abstentions.","Warrants are exercisable into common stock at $3.44 per share; approval covers underlying shares.","Annual Meeting reconvened on August 29, 2025; quorum of 58.5% of outstanding shares present."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.15,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":136402,"accession_number":"0001641172-25-021597","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2025-07-30T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Nasdaq grants Iveda Solutions extension to Nov 24, 2025 to regain equity compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Stockholders' equity of $1.7M as of March 31, 2025 fell below Nasdaq's $2.5M minimum.","Extension granted July 23, 2025; deadline to regain compliance is November 24, 2025.","If compliance not regained, Nasdaq may delist; company can appeal to a Hearing Panel.","Company previously disclosed May 27, 2025 non-compliance letter from Nasdaq."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":153548,"accession_number":"0001641172-25-014074","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2025-06-06T23:59:59+00:00","items":["5.07","8.01"],"status":"ready","headline":"Iveda Solutions' 2024 Annual Meeting fails to approve warrant issuance; adjourned to Aug 29","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["At reconvened 2024 Annual Meeting on June 2, 2025, Proposal 5 (issuance of 625K Series A and B warrants and underlying shares) did not receive sufficient votes.","Meeting was adjourned to August 29, 2025, at 9:30 a.m. Mountain Time to allow additional time for stockholder voting on Proposal 5.","1,309,385 shares present (54.37% of outstanding voting capital), constituting a quorum."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":153547,"accession_number":"0001641172-25-013078","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2025-05-30T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Iveda receives Nasdaq deficiency notice for stockholders' equity below $2.5M","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["As of March 31, 2025, stockholders' equity was $1.7M, below Nasdaq's $2.5M minimum.","Company has until July 11, 2025 to submit a plan to regain compliance.","If plan accepted, company has until November 22, 2025 to evidence compliance.","No immediate impact on listing; trading continues pending compliance efforts.","Company intends to take reasonable measures but cannot assure success."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":153546,"accession_number":"0001641172-25-004772","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2025-04-15T23:59:59+00:00","items":["4.02"],"status":"ready","headline":"Iveda Solutions restates 2023 & 2024 financials; net losses increase by $1.4M-$1.6M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Restatement due to multiple errors including improper capitalization of software dev costs, deferred tax asset write-off, and intercompany payable.","Net loss for nine months ended Sep 30, 2023 restated to $2.68M from $2.14M; loss per share changed from $0.13 to $0.27.","Net loss for nine months ended Sep 30, 2024 restated to $2.47M from $2.16M; loss per share went from $0.13 to $1.24.","Former auditor BF Borgers banned by SEC; company engaged Weinberg & Co to re-audit 2023 and 2024 financials."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":172272,"accession_number":"0001493152-25-009586","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2025-03-07T23:59:59+00:00","items":["5.07","8.01"],"status":"ready","headline":"Iveda shareholders approve redomicile to Delaware; warrant issuance vote adjourned to June 2","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Redomicile from Nevada to Delaware approved: 1,233,381 for, 21,273 against, 19,553 abstained.","Proposal 4 (increase authorized shares) no longer required given redomicile approval.","Proposal 5 (issuance of 625K Series A and 625K Series B warrants) did not pass; meeting adjourned to June 2, 2025, at 9:30 a.m. MT.","Adjourned meeting will be held at Iveda's offices in Mesa, AZ; quorum was 54.37% of outstanding shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":172271,"accession_number":"0001493152-25-009177","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2025-03-05T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Iveda Solutions enters ATM offering agreement with H.C. Wainwright for up to $5.08M in common stock","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Agreement with H.C. Wainwright & Co. to sell up to $5,082,431 of common stock in at-the-market offerings.","Sales made only upon Company instruction; no obligation to sell any shares.","Commission of 3.0% of gross sales price plus up to $50,000 expense reimbursement and $5,000 per due diligence update.","Offered under existing shelf registration (Form S-3 No. 333-276676) and prospectus supplement dated February 27, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":172270,"accession_number":"0001493152-25-008158","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2025-02-25T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Iveda Solutions dismisses Kreit & Chiu CPA LLP, appoints Weinberg & Company as auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dismissed Kreit & Chiu CPA LLP as independent auditor effective February 21, 2025.","Appointed Weinberg & Company, P.A. as new independent registered public accounting firm.","No disagreements with Kreit on accounting principles or disclosures; no reportable events."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189263,"accession_number":"0001493152-24-049479","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2024-12-10T23:59:59+00:00","items":["5.07","8.01"],"status":"ready","headline":"Iveda Solutions adjourns annual meeting to March 4, 2025 after three proposals fail to get enough votes","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders re-elected directors Farnsworth, Franco, Gillen, Ly (615-34K for each).","Ratified Kreit & Chiu CPA as auditor for FY 2024 (1,290,308 for, 2,678 against).","Proposals to redomicile to Delaware, increase authorized shares, and issue warrants received insufficient votes.","Annual meeting adjourned to March 4, 2025 at 9:30 a.m. MT to allow additional voting time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205758,"accession_number":"0001493152-24-036197","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2024-09-13T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Iveda Solutions 1-for-8 reverse stock split effective Sept 17, 2024 to meet Nasdaq bid price rule","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["1-for-8 reverse stock split expected effective at market open on September 17, 2024; shares to trade under same symbol IVDA with new CUSIP 46583A303.","Outstanding shares reduced from ~18,069,891 to ~2,258,737; authorized shares cut from 37,500,000 to 4,687,500.","Publicly traded warrants (IVDAW) adjusted: each 8 warrants now buy 1 share at $34.00 ($4.25 per warrant); CUSIP unchanged.","Reverse stock split aimed at satisfying Nasdaq $1.00 minimum bid price requirement under Listing Rule 5550(a)(2); no stockholder vote required."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205757,"accession_number":"0001493152-24-035838","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2024-09-11T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Iveda Solutions effects 1-for-4 reverse stock split, authorized shares cut to 9.375M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split at 1:4 ratio; outstanding shares drop from ~18.07M to ~4.52M.","Authorized shares reduced from 37.5M to 9.375M via Certificate of Change filed with Nevada.","No fractional shares issued; fractional shares rounded up to nearest whole number.","New CUSIP number 46583A 303 assigned; trading symbol IVDA unchanged.","Outstanding warrants and options will be adjusted proportionally."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205756,"accession_number":"0001493152-24-035356","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2024-09-06T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Iveda Solutions raises ~$2.15M in registered direct offering and private placement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 1.8M shares at $0.43/share and pre-funded warrants for 3.2M shares at $0.429/warrant; gross proceeds ~$2.15M.","Concurrent private placement: unregistered Series A and B warrants to purchase up to 10M shares at $0.43, exercisable after stockholder approval.","Net proceeds for working capital and general corporate purposes; offering closed September 6, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":222709,"accession_number":"0001493152-24-019326","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2024-05-14T23:59:59+00:00","items":["4.01"],"status":"ready","headline":"Iveda dismisses BF Borgers as auditor after SEC order; appoints Kreit & Chiu","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dismissed BF Borgers CPA PC on May 9, 2024, following SEC administrative order dated May 3, 2024.","Audit reports for FY 2022 and 2023 had no adverse opinion, qualification, or disagreement.","No reportable events or disagreements with former auditor during the two most recent fiscal years.","Appointed Kreit & Chiu CPA LLP as new independent auditor on May 10, 2024, for FY 2024.","No prior consultations with Kreit regarding accounting principles or disagreements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":242202,"accession_number":"0001493152-24-011540","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2024-03-27T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Iveda Solutions gets 180-day Nasdaq bid-price extension to Sept 23, 2024","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq extended compliance period to September 23, 2024 for minimum $1.00 bid price.","Company must achieve $1.00 closing bid for 10 consecutive days or consider reverse stock split.","If not cured by Sept 23, 2024, Nasdaq will delist; company may appeal to Hearings Panel.","Extension granted because Iveda meets all other continued listing requirements except bid price."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":242201,"accession_number":"0001493152-24-000657","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2024-01-04T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Iveda Solutions President Sid Sung resigns; CEO David Ly appointed President","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Sid Sung resigned as President effective Dec 31, 2023, for personal reasons.","David Ly, Chairman and CEO, appointed as President on Dec 31, 2023.","Ly continues as CEO; no other officer changes announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":259607,"accession_number":"0001493152-23-039960","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2023-11-09T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Iveda annual meeting passes four proposals; directors elected, auditor ratified, say-on-pay approved","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Directors Farnsworth, Franco, Gillen, and Ly elected with 3.0-3.2M votes each; broker non-votes 4.78M.","Ratification of BF Borgers CPA PC as auditor for FY2023: 8,066,993 for vs. 56,732 against, no broker non-votes.","Advisory vote on executive compensation frequency: three years approved (2.47M votes); 543K favored one year.","Advisory vote on named executive officer compensation for FY2022 approved: 2.92M for, 316K against.","Meeting had quorum of 8,142,978 shares (50.85% of eligible votes)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":276872,"accession_number":"0001493152-23-034864","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2023-09-29T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Nasdaq notifies Iveda Solutions of non-compliance with minimum bid price rule","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Closing bid price of common stock below $1.00 for 30 consecutive trading days.","Initial compliance period of 180 days until March 26, 2024, to regain compliance.","Common stock continues trading on Nasdaq under symbol \"IVDA\" with no immediate effect.","If not cured by March 26, may seek additional 180-day period if other listing standards met.","Company intends to monitor bid price and consider options; no assurance of compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":315303,"accession_number":"0001493152-23-005288","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2023-02-16T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Iveda Solutions regains Nasdaq minimum bid price compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Iveda on Feb 15, 2023, that its common stock closed at $1.00+ for 10 consecutive business days.","The minimum bid price deficiency under Nasdaq Listing Rule 5550(a)(2) is now cured and the matter is closed.","This removes the immediate risk of delisting from the Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":315302,"accession_number":"0001493152-23-000240","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2023-01-04T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Iveda Solutions CMO/COO Luz Berg resigns; CFO Brilon named Corporate Secretary","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Luz Berg resigned as CMO, COO and Corporate Secretary on Dec 31, 2022 for personal reasons.","Robert J Brilon, CFO and Treasurer, appointed as Corporate Secretary effective Dec 31, 2022.","No other changes to executive management were disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":333641,"accession_number":"0001493152-22-029347","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2022-10-21T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Iveda Solutions receives Nasdaq deficiency notice for bid price below $1.00 for 30 days","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on Oct 18, 2022 for non-compliance with minimum $1.00 bid price requirement; bid price below $1.00 for 30 consecutive trading days.","Has 180-day compliance period until April 17, 2023 to regain compliance by closing bid price ≥$1.00 for 10 consecutive trading days.","If not compliant by April 17, 2023, may qualify for additional 180-day period if it meets other listing requirements.","Stock continues trading on Nasdaq Capital Market under symbol IVDA during cure period; delisting possible if not cured."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":351103,"accession_number":"0001493152-22-022406","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2022-08-12T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Iveda Solutions raises $5M via private placement of stock and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of $5M from sale of 3,289,474 shares (or pre-funded warrants) at $1.52/unit and 3,289,474 warrants.","Warrants exercisable at $1.40/share, immediately exercisable for 5.5 years from issuance.","Net proceeds to be used for working capital and general corporate purposes.","Maxim Group acted as sole placement agent with 7% cash fee on gross proceeds.","Company to file resale registration statement with SEC by August 24, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":368372,"accession_number":"0001493152-22-009287","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2022-04-06T23:59:59+00:00","items":["1.01","5.03","7.01","9.01"],"status":"ready","headline":"Iveda closes $8M public offering, completes 1-for-8 reverse stock split, uplists to Nasdaq","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of $8.0M from offering of 1,885,000 shares and 2,164,700 warrants (including over-allotment) at $4.25 per unit.","Reverse stock split at 1-for-8 effective March 31, 2022; authorized shares reduced accordingly.","Common stock and warrants began trading on Nasdaq Capital Market on April 1, 2022 under symbols IVDA and IVDAW.","Warrants exercisable at $4.25 per share, expire in 5 years.","Net proceeds to be used for product development, marketing, business development, and working capital."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":387689,"accession_number":"0001493152-22-002192","cik":1397183,"company_name":"Iveda Solutions, Inc.","ticker":"IVDA","form_type":"8-K","filed_at":"2022-01-25T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Shareholders approve doubling of authorized common stock to 300M shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Special meeting held Jan 21, 2022; 49,980,029 shares voted, representing 63.83% of outstanding.","Proposal 1 to increase authorized common stock from 200M to 300M passed with 97.51% of votes cast.","Total authorized capital stock raised to 400M shares (300M common + 100M blank-check preferred).","Certificate of amendment filed with Nevada Secretary of State on Jan 25, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":3766899.8534810133,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}